These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36287578)

  • 1. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women.
    González R; Nhampossa T; Figueroa-Romero A; Mendes A; Mazuze M; García-Otero L; Sevene E; Piqueras M; Egri N; Bedini JL; Saúte F; Menendez C
    J Acquir Immune Defic Syndr; 2023 Feb; 92(2):115-121. PubMed ID: 36287578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence and preeclampsia markers in Mozambican pregnant women with perinatal loss.
    Chileshe M; Nhampossa T; Carrilho C; Mendes A; Luis E; Sacarlal J; Navero-Castillejos J; Morales-Ruiz M; Martínez MJ; Ordi J; Rakislova N; Menendez C; González R
    BMC Pregnancy Childbirth; 2024 Sep; 24(1):609. PubMed ID: 39300353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
    Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
    Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic.
    Figueroa-Romero A; Atchadé A; Yadouleton A; Fiogbe M; Bonnet E; Yovo E; Accrombessi M; Hounsa S; Paper T; Dupont R; Gaudart J; Le Hesran JY; Massougbodji A; Cottrell G; González R
    BMC Public Health; 2024 Jul; 24(1):1762. PubMed ID: 38956517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 in Mozambican primary school-aged children at Maputo City and Province: a cross-sectional study from a low-income country.
    Bauhofer AFL; Ussivane É; Chissaque A; Iahaia F; Pololo R; Campos F; Miranda E; António L; Maholela P; Gatambire A; Djedje M; Ráice F; Gonçalves L; de Deus N; Inlamea O
    BMC Pediatr; 2024 Jul; 24(1):425. PubMed ID: 38956534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique.
    Benoni R; Casigliani V; Zin A; Giannini D; Ronzoni N; Di Chiara C; Chhaganlal K; Donà D; Merolle A; Dos Anjos HG; Chenene F; Tognon F; Putoto G; Giaquinto C
    BMC Infect Dis; 2023 Nov; 23(1):809. PubMed ID: 37978353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
    Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
    Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.
    Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J;
    Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High SARS-CoV-2 Exposure in Rural Southern Mozambique After Four Waves of COVID-19: Community-Based Seroepidemiological Surveys.
    de Jesus Á; Ernesto R; Massinga AJ; Nhacolo F; Munguambe K; Timana A; Nhacolo A; Messa A; Massora S; Escola V; Enosse S; Gunjamo R; Funzamo C; Mwenda JM; Okeibunor J; Garcia-Basteiro A; Guinovart C; Mayor A; Mandomando I
    Influenza Other Respir Viruses; 2024 Jun; 18(6):e13332. PubMed ID: 38838093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
    Vercoutere A; Zina MJ; Telis M; Goffard JC; Boulvain M; de Doncker L; Derisbourg S; Houben S; Delforge ML; Daelemans C; Kelen D
    BMC Infect Dis; 2024 May; 24(1):509. PubMed ID: 38773493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
    Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.
    Hookham L; Cantrell L; Cose S; Freyne B; Gadama L; Imede E; Kawaza K; Lissauer S; Musoke P; Nankabirwa V; Sekikubo M; Sommerfelt H; Voysey M; Le Doare K;
    PLoS One; 2024; 19(3):e0290913. PubMed ID: 38427691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
    Aissatou A; Fokam J; Semengue ENJ; Takou D; Ka'e AC; Ambe CC; Nka AD; Djupsa SC; Beloumou G; Ciaffi L; Tchouaket MCT; Nayang ARM; Pabo WLT; Essomba RG; Halle EGE; Okomo MC; Bissek AZ; Leke R; Boum Y; Mballa GAE; Montesano C; Perno CF; Colizzi V; Ndjolo A
    Front Immunol; 2023; 14():1155855. PubMed ID: 37090738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey.
    McAuley A; Gousias P; Hasan T; Rashid L; Richardson C; Reid G; Templeton K; McGuire J; Wise H; McVicar L; Jenks S; Gunn R; Dickson E; Stock SJ; Stockton A; Waugh C; Wood R; McMenamin J; Robertson C; Goldberg DJ; Palmateer NE
    Public Health; 2021 Oct; 199():17-19. PubMed ID: 34517289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring SARS-CoV-2 seroprevalence over time among pregnant women admitted to delivery units: Suitability for surveillance.
    Miyadahira MY; Brizot ML; Alexander N; Cerdeira Sabino E; Campos de Oliveira da Silva L; Hoshida MS; da Silva Sousa Oliveira AM; Silva Farche AC; Pulcineli Vieira Francisco R; Mayaud P
    PLoS One; 2023; 18(1):e0280109. PubMed ID: 36603011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and vaccine antibody prevalence in a multi-ethnic inner-city antenatal population: A cross-sectional surveillance study.
    Andreeva D; Gill C; Brockbank A; Hejmej J; Conti-Ramsden F; Doores KJ; Seed PT; Poston L;
    BJOG; 2023 Aug; 130(9):1135-1144. PubMed ID: 37113111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.